US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NEWAMSTERDAM PHARMA CO NV

19.54

+0.98505.31%

Volume:337.17K

Turnover:6.47M

Market Cap:2.15B

PE:-7.63

High:19.57

Open:18.40

Low:17.77

Close:18.55

Loading ...

Overview Company News Filings

NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in March

Both private equity firms who control a good portion of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) along with institutions must be dismayed after last week's 8.1% decrease

Simply Wall St.

Newamsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Novartis Edges Higher On Sales Beat As Competition Looms For Its Biggest Moneymaker

NewAmsterdam Pharma to Present at Guggenheim’s SMID Cap Biotech Conference

NewAmsterdam Pharma Price Target Maintained With a $40.00/Share by RBC Capital

RBC Capital Sticks to Their Buy Rating for NewAmsterdam Pharma Company (NAMS)

NewAmsterdam Pharma Price Target Maintained With a $40.00/Share by RBC Capital

RBC Capital Sticks to Their Buy Rating for NewAmsterdam Pharma Company (NAMS)

NewAmsterdam Pharma Price Target Maintained With a $48.00/Share by HC Wainwright & Co.

NewAmsterdam Pharma Highlights 2024 Achievements and Outlines 2025 Strategic Priorities

HC Wainwright Initiates NewAmsterdam Pharma at Buy With $48 Price Target

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and NewAmsterdam Pharma Company (NAMS)

NewAmsterdam Pharma initiated with a Buy at H.C. Wainwright

NewAmsterdam Pharma Company Nv : H.c. Wainwright Initiates Coverage With Buy Rating; Target Price $48

THOMSON REUTERS

Walgreens Boots Alliance, Alaska Air And RH Are Among Top Mid-Cap Gainers Last Week (December 9-13): Are The Others In Your Portfolio?

Press Release: NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

NewAmsterdam Pharma Prices $416.5 Million Public Offering

MT Newswires Live

Stock Track | NewAmsterdam Pharma Plunges 5.65% on Positive Phase III Trial Results for CETP Inhibitor

Esperion selloff continues following competitor data from NewAmsterdam

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NAMS/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NAMS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAMS\",,,,,undefined,":{"symbol":"NAMS","market":"US","secType":"STK","nameCN":"NEWAMSTERDAM PHARMA CO NV","latestPrice":19.535,"timestamp":1746030717080,"preClose":18.55,"halted":0,"volume":337170,"delay":0,"floatShares":53941586,"shares":109817812,"eps":-2.560438,"marketStatus":"Trading","change":0.985,"latestTime":"04-30 12:32:04 EDT","open":18.4,"high":19.57,"low":17.7677,"amount":6467481.98805,"amplitude":0.097159,"askPrice":19.58,"askSize":404,"bidPrice":19.49,"bidSize":221,"shortable":3,"etf":0,"ttmEps":-2.560438,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746043200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":18.55,"preHourTrading":{"tag":"盘前","latestPrice":18.52,"preClose":18.55,"latestTime":"09:29 EDT","volume":211,"amount":3914.88978,"timestamp":1746019792022},"postHourTrading":{"tag":"盘后","latestPrice":18.55,"preClose":18.55,"latestTime":"16:52 EDT","volume":8346,"amount":154826.51,"timestamp":1745959936204},"volumeRatio":1.685173,"impliedVol":1.1553,"impliedVolPercentile":0.732},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAMS\",,,,,undefined,":{"symbol":"NAMS","floatShares":53941586,"roa":"-18.19%","roe":"-46.20%","lyrEps":-2.560438,"volumeRatio":1.685173,"shares":109817812,"dividePrice":0,"high":19.57,"amplitude":0.097159,"preClose":18.55,"low":17.7677,"week52Low":14.06,"pbRate":"2.83","psRate":"47.08","week52High":27.29,"institutionHeld":0,"latestPrice":19.535,"committee":-0.2928,"eps":-2.560438,"divideRate":0,"volume":337170,"delay":0,"ttmEps":-2.560438,"open":18.4,"prevYearClose":25.7,"prevWeekClose":17.52,"prevMonthClose":20.47,"prevQuarterClose":20.47,"fiveDayClose":17.27,"twentyDayClose":18.38,"sixtyDayClose":21.36},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NAMS\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514099828","title":"NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in March","url":"https://stock-news.laohu8.com/highlight/detail?id=2514099828","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514099828?lang=en_us&edition=fundamental","pubTime":"2025-02-25 21:00","pubTimestamp":1740488400,"startTime":"0","endTime":"0","summary":"NAARDEN, The Netherlands and MIAMI, Feb. 25, 2025  -- NewAmsterdam Pharma Company N.V. , a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease  with elevated low-density lipoprotein cholesterol , for whom existing therapies are not sufficiently effective or well-tolerated, today announced that company management will participate in the following upcoming investor conferences:. TD Cowen 45th Annual Healthcare Conference in Boston, MA on Tuesday, March 4 and Wednesday, March 5, 2025. Michael Davidson, M.D., Chief Executive Officer, and Ian Somaiya, Chief Financial Officer, will present a corporate overview at 1:50 p.m. ET on Tuesday, March 4.Leerink Partners Global Healthcare Conference 2025 in Miami, FL on Monday, March 10, 2025. Michael Davidson, M.D., Chief Executive Officer, will present a corporate overview at 8:00 a.m. ET.Investor ContactPrecision AQ on behalf of NewAmsterdamAustin MurtaghP: 1-212-698-8","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/newamsterdam-pharma-participate-upcoming-investor-130000865.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NAMS","NAMSW","BK4139"],"gpt_icon":0},{"id":"2511695490","title":"Both private equity firms who control a good portion of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) along with institutions must be dismayed after last week's 8.1% decrease","url":"https://stock-news.laohu8.com/highlight/detail?id=2511695490","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511695490?lang=en_us&edition=fundamental","pubTime":"2025-02-14 22:01","pubTimestamp":1739541678,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma's significant private equity firms ownership suggests that the key decisions are influenced by shareholders from the larger public. A total of 6 investors have a majority stake in the company with 53% ownership. 34% of NewAmsterdam Pharma is held by Institutions. If you want to know who really controls NewAmsterdam Pharma Company N.V. , then you'll have to look at the makeup of its share registry. We can see that private equity firms own the lion's share in the company with 42% ownership. Put another way, the group faces the maximum upside potential .While the holdings of private equity firms took a hit after last week’s 8.1% price drop, institutions with their 34% holdings also suffered.Let's delve deeper into each type of owner of NewAmsterdam Pharma, beginning with the chart below.Check out our latest analysis for NewAmsterdam Pharma. What Does The Institutional Ownership Tell Us About NewAmsterdam Pharma?While it makes sense to study institutional ownership data","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/both-private-equity-firms-control-140118208.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SQQQ",".IXIC","MNQmain","BK4139","USAW.SI","LU2095319765.USD","BK4585","NAMSW","QLD","BK4588","IE00B64PRP62.GBP","NVIW.SI","NDAQ","IE00B3QW5Z07.USD","LU2210149790.SGD","TSYW.SI","IE00BKPKM429.USD","QID","NQmain","TQQQ","IE00BGHQF748.EUR","LU2210150020.SGD","USJW.SI","PSQ","BK4112","NAMS"],"gpt_icon":1},{"id":"2509771541","title":"Newamsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2509771541","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509771541?lang=en_us&edition=fundamental","pubTime":"2025-02-08 05:20","pubTimestamp":1738963208,"startTime":"0","endTime":"0","summary":"Feb 7 (Reuters) - NewAmsterdam Pharma Company NV ::*NEWAMSTERDAM PHARMA REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 07-FEB-202521:01:00.127 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250207:nRSD5xMDLB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NAMS"],"gpt_icon":0},{"id":"2507961169","title":"Novartis Edges Higher On Sales Beat As Competition Looms For Its Biggest Moneymaker","url":"https://stock-news.laohu8.com/highlight/detail?id=2507961169","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507961169?lang=en_us&edition=fundamental","pubTime":"2025-01-31 23:19","pubTimestamp":1738336784,"startTime":"0","endTime":"0","summary":"Novartis stock rose Friday after the drugmaker beat fourth-quarter expectations, largely on the back of its heart failure drug Entresto.","market":"fut","thumbnail":"https://www.investors.com/wp-content/uploads/2018/04/STOCK-Novartis-02-shutter-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2018/04/STOCK-Novartis-02-shutter-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/news/technology/novartis-stock-novartis-earnings-q4-2024/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["LU0061475181.USD","LU2063271972.USD","AMGN","LU0096364046.USD","LU0882574055.USD","LU1366192091.USD","LU1868837300.USD","LU2491050154.USD","LU1974910355.USD","NVS","SG9999015945.SGD","LU1057294990.SGD","SG9999001440.SGD","LU0114720955.EUR","LU0109391861.USD","LU1989771016.USD","LU2237443978.SGD","NAMS","IE00BK4W5L77.USD","LU0058720904.USD","BK4588","LU0354030511.USD","SG9999001176.USD","SG9999018865.SGD","LLY","BK4566","LU2089984988.USD","SG9999014914.USD","SG9999014906.USD","LU0256863811.USD","LU1127390331.HKD","LU0882574139.USD","SG9999014880.SGD","LU0238689110.USD","LU2106854487.HKD","IE0009355771.USD","BK4007","LU0320765059.SGD","CRSP","SG9999015952.SGD","LU1988902786.USD","IE0002141913.USD","BK4532","IONS","LU2361044949.HKD","LU0256863902.USD","SGXZ57979304.SGD","SGXZ31699556.SGD","LU0122379950.USD","LU0198837287.USD"],"gpt_icon":1},{"id":"2507638909","title":"NewAmsterdam Pharma to Present at Guggenheim’s SMID Cap Biotech Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2507638909","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507638909?lang=en_us&edition=fundamental","pubTime":"2025-01-29 21:00","pubTimestamp":1738155600,"startTime":"0","endTime":"0","summary":"NAARDEN, The Netherlands and MIAMI, Jan. 29, 2025  -- NewAmsterdam Pharma Company N.V. , a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease  with elevated low-density lipoprotein cholesterol , for whom existing therapies are not sufficiently effective or well-tolerated, today announced that Ian Somaiya, Chief Financial Officer of NewAmsterdam Pharma, will participate in a fireside chat at the Guggenheim SMID Cap Biotech Conference on Wednesday, February 5, 2025 at 10:00 a.m. ET.NewAmsterdam Pharma  is a late-stage biopharmaceutical company whose mission is to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. We seek to fill a significant unmet need for a safe, well-tolerated and convenient LDL-lowering therapy. In multiple phase 3 trials, NewAmsterdam is investigating obicetrapib, an oral, low-dose and once-daily CETP ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/newamsterdam-pharma-present-guggenheim-smid-130000812.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NAMS","SMID","BK4011","NAMSW"],"gpt_icon":0},{"id":"2506251205","title":"NewAmsterdam Pharma Price Target Maintained With a $40.00/Share by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2506251205","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506251205?lang=en_us&edition=fundamental","pubTime":"2025-01-28 23:04","pubTimestamp":1738076640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NAMS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 28, 2025 10:04 ET (15:04 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMS"],"gpt_icon":0},{"id":"2506928365","title":"RBC Capital Sticks to Their Buy Rating for NewAmsterdam Pharma Company (NAMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2506928365","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506928365?lang=en_us&edition=fundamental","pubTime":"2025-01-28 19:37","pubTimestamp":1738064257,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Leonid Timashev maintained a Buy rating on NewAmsterdam Pharma Company (NAMS – Research Report) today and set a price target of...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-buy-rating-for-newamsterdam-pharma-company-nams-5?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-buy-rating-for-newamsterdam-pharma-company-nams-5?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NAMS"],"gpt_icon":0},{"id":"2506997828","title":"NewAmsterdam Pharma Price Target Maintained With a $40.00/Share by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2506997828","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506997828?lang=en_us&edition=fundamental","pubTime":"2025-01-25 02:22","pubTimestamp":1737742920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NAMS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 24, 2025 13:22 ET (18:22 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMS"],"gpt_icon":0},{"id":"2505569618","title":"RBC Capital Sticks to Their Buy Rating for NewAmsterdam Pharma Company (NAMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2505569618","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505569618?lang=en_us&edition=fundamental","pubTime":"2025-01-24 19:58","pubTimestamp":1737719895,"startTime":"0","endTime":"0","summary":"In a report released today, Leonid Timashev from RBC Capital maintained a Buy rating on NewAmsterdam Pharma Company (NAMS – Research Report), with ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-buy-rating-for-newamsterdam-pharma-company-nams-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-sticks-to-their-buy-rating-for-newamsterdam-pharma-company-nams-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NAMS"],"gpt_icon":0},{"id":"2503217527","title":"NewAmsterdam Pharma Price Target Maintained With a $48.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2503217527","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503217527?lang=en_us&edition=fundamental","pubTime":"2025-01-14 20:59","pubTimestamp":1736859540,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NAMS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 14, 2025 07:59 ET (12:59 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMS"],"gpt_icon":0},{"id":"2502863350","title":"NewAmsterdam Pharma Highlights 2024 Achievements and Outlines 2025 Strategic Priorities","url":"https://stock-news.laohu8.com/highlight/detail?id=2502863350","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502863350?lang=en_us&edition=fundamental","pubTime":"2025-01-10 21:00","pubTimestamp":1736514000,"startTime":"0","endTime":"0","summary":"-- Additional data from BROADWAY, BROOKLYN, and TANDEM to be presented throughout 2025; expected to support global regulatory filings for obicetrapib, including EMA submission in 2H25 by our partner Menarini –。-- Data from Phase 2 VINCENT trial expected by 2H25, which explores effect of obicetrapib alone and in combination with a PCSK9i on Lp –。-- Focus on commercial readiness with manufacturing capacity establishment and inventory build-out --. NewAmsterdam is developing obicetrapib, an oral, low-dose, once-daily, and highly selective cholesteryl ester transfer protein  inhibitor, alone or as a fixed-dose combination with ezetimibe, as preferred LDL-C lowering therapies to be used as an adjunct to statin therapy for patients at risk of cardiovascular disease with elevated LDL-C, for whom existing therapies are not sufficiently effective or well tolerated.The Company’s global, pivotal Phase 3 clinical development program consists of four trials in over 12,250 patients.“As we move into ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/newamsterdam-pharma-highlights-2024-achievements-130000617.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NAMSW","NAMS","BK4139"],"gpt_icon":0},{"id":"2495546869","title":"HC Wainwright Initiates NewAmsterdam Pharma at Buy With $48 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2495546869","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495546869?lang=en_us&edition=fundamental","pubTime":"2024-12-30 20:18","pubTimestamp":1735561137,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma (NAMS) has an average rating of buy and mean price target of $43.44, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NAMS"],"gpt_icon":0},{"id":"2495585543","title":"Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and NewAmsterdam Pharma Company (NAMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2495585543","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495585543?lang=en_us&edition=fundamental","pubTime":"2024-12-30 19:40","pubTimestamp":1735558851,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Legend Biotech (LEGN – Research Report) and NewAmste...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-legend-biotech-legn-and-newamsterdam-pharma-company-nams?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-legend-biotech-legn-and-newamsterdam-pharma-company-nams?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","NAMS","LEGN","BK4137","BK4588","BK4585","BK4505","BK4139"],"gpt_icon":0},{"id":"2495548857","title":"NewAmsterdam Pharma initiated with a Buy at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2495548857","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495548857?lang=en_us&edition=fundamental","pubTime":"2024-12-30 19:15","pubTimestamp":1735557320,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Ed Arce initiated coverage of NewAmsterdam Pharma (NAMS) with a Buy rating and $48 price target NewAmsterdam is a late-stag...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/newamsterdam-pharma-initiated-with-a-buy-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/newamsterdam-pharma-initiated-with-a-buy-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NAMS","BK4139"],"gpt_icon":0},{"id":"2495517206","title":"NewAmsterdam Pharma Company Nv : H.c. Wainwright Initiates Coverage With Buy Rating; Target Price $48","url":"https://stock-news.laohu8.com/highlight/detail?id=2495517206","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495517206?lang=en_us&edition=fundamental","pubTime":"2024-12-30 19:13","pubTimestamp":1735557193,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nFWN3NP0DL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NAMS","BK4139"],"gpt_icon":0},{"id":"2491109576","title":"Walgreens Boots Alliance, Alaska Air And RH Are Among Top Mid-Cap Gainers Last Week (December 9-13): Are The Others In Your Portfolio?","url":"https://stock-news.laohu8.com/highlight/detail?id=2491109576","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491109576?lang=en_us&edition=fundamental","pubTime":"2024-12-15 23:00","pubTimestamp":1734274838,"startTime":"0","endTime":"0","summary":"These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio?Patterson Companies, Inc.  stock rocketed 35.60%after the company announced it entered into a definitive agreement to be acquired by Patient Square Capital forapproximately$4.1 billion.NewAmsterdam Pharma Company N.V.  shares jumped 34.55% after the company announced topline data from its Phase 3 BROADWAY trial of Obicetrapib.Walgreens Boots Alliance, Inc.  gained 21.38% last week following a report from Sky News indicating that Sycamore Partners has approached various potential lenders to fund a possible acquisition of the company.NovoCure Limited  stock rose 19.49%. Piper Sandler maintained an Overweight rating and raised the price target to$42.RH  shares surged 18.60% after the company reported quarterly results and raised itsguidance. Also, Baird maintained a Neutral rating on the stock and raised its price target from $300 to $400.Pactiv Evergreen Inc.  stock upped 17.71% after the compa","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/c6vN9mcR17ruCxXcU23Kgw--~B/aD01NzY7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/a177fa4930a8f88fa1bae43e9a5b7a4a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/c6vN9mcR17ruCxXcU23Kgw--~B/aD01NzY7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/a177fa4930a8f88fa1bae43e9a5b7a4a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/walgreens-boots-alliance-alaska-air-150038320.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","BK4128","BK4175","QLD","USAW.SI","BK4585","BK4008","NVCR","MNQmain","BK4539","BK4178","PDCO","BK4082","LU0823414478.USD","STVN","BK4567","BK4133","BK4500","BK4548","TQQQ","RH","NAMS","BK4139","BK4213","BK4559","NQmain","TSYW.SI","USJW.SI","RNW","WBA","LU2294711713.HKD","CRK","QID","BK4534","LU2357125470.USD","PSQ","SQQQ","LU0823414551.USD","LU2249611893.SGD",".IXIC","PTVE","LU0321505868.SGD","LU0321505439.SGD","LU2506951792.HKD","BK4136","NVIW.SI","BK4121","ALK"],"gpt_icon":1},{"id":"2491894935","title":"Press Release: NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters' Option to Purchase Additional Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2491894935","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491894935?lang=en_us&edition=fundamental","pubTime":"2024-12-14 06:16","pubTimestamp":1734128160,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters' Option to Purchase Additional Shares. The net proceeds to the Company from the Offering, including the proceeds from the exercise by the underwriters of their option to purchase the additional shares, were approximately $452.6 million after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company.Jefferies, Goldman Sachs & Co., Leerink Partners, TD Cowen, Guggenheim Securities and William Blair acted as joint book-running managers for the Offering.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B19Z3B42.SGD","IE0004091025.USD","BK4585","LU2237443978.SGD","LU2237443622.USD","BK4127","BK4533","BK4550","LU2237443895.HKD","NAMS","BK4139","BK4504","IE00B19Z3581.USD","BK4552","LU1791807156.HKD","LU2237443465.HKD","LU2237438978.USD","IE0004086264.USD","LU0106831901.USD","LU1668664300.SGD","LU2237443382.USD","BK4516","USA","IE00BSNM7G36.USD","IE0002270589.USD","LU2237443549.SGD","IE0034235188.USD","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2490126803","title":"NewAmsterdam Pharma Prices $416.5 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2490126803","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490126803?lang=en_us&edition=fundamental","pubTime":"2024-12-12 18:30","pubTimestamp":1733999411,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma  said late Wednesday it has priced an underwritten public offering of 12.1 million shares at $24.50 per share and pre-funded warrants to purchase 4.9 million shares at $24.4999 per warrant.The company said it has also granted underwriters a 30-day option to purchase up to 2.6 million additional sharesThe company said it expects gross proceeds from the offering, anticipated to close on Thursday, of $416.5 million.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NAMS","BK4139"],"gpt_icon":0},{"id":"1134531644","title":"Stock Track | NewAmsterdam Pharma Plunges 5.65% on Positive Phase III Trial Results for CETP Inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=1134531644","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134531644?lang=en_us&edition=fundamental","pubTime":"2024-12-12 00:18","pubTimestamp":1733933906,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma Co NV's stock experienced a significant plummet of 5.65% during Wednesday's intraday trading session. This decline followed the company's announcement of positive topline results from the Phase III clinical trial of its novel CETP inhibitor drug.The promising trial data for NewAmsterdam Pharma's CETP inhibitor, which targets cholesterol management, has raised concerns among investors about potential competition for existing drugs in the same therapeutic area. Consequently, sh","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Stock Track | NewAmsterdam Pharma Plunges 5.65% on Positive Phase III Trial Results for CETP Inhibitor","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["NAMS"],"gpt_icon":0},{"id":"2490862895","title":"Esperion selloff continues following competitor data from NewAmsterdam","url":"https://stock-news.laohu8.com/highlight/detail?id=2490862895","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490862895?lang=en_us&edition=fundamental","pubTime":"2024-12-12 00:00","pubTimestamp":1733932815,"startTime":"0","endTime":"0","summary":"Jefferies says Esperion (ESPR) shares have pulled back on competitor NewAmsterdam Pharma’s (NAMS) Phase III topline for its novel CETP inhibitor, w...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/esperion-selloff-continues-following-competitor-data-from-newamsterdam?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/esperion-selloff-continues-following-competitor-data-from-newamsterdam?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4139","ESPR","NAMS"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":65,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NAMS\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NAMS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NAMS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4545,"buy":0.4545,"hold":0.0909,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4545,"analysts":11,"updateTime":1743480000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NAMS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NAMS","date":"2025-04-28","current":-7.963675,"percent":0.607729,"low":-24.522784,"twenty":-21.129609,"median":-11.007855,"eighty":-4.032133,"high":37.547018,"avg":-9.766655,"sd":12.965102,"marketCap":1924008066},"quantilePoints":[{"date":"2021-02-12","current":-21.838475,"twenty":-21.935278,"median":-21.828934,"eighty":-21.349311,"marketCap":152162640},{"date":"2021-02-19","current":-21.896664,"twenty":-21.861751,"median":-21.619037,"eighty":-21.46054,"marketCap":152734680},{"date":"2021-02-26","current":-21.012022,"twenty":-21.861751,"median":-21.551533,"eighty":-21.347758,"marketCap":146156220},{"date":"2021-03-05","current":-21.131171,"twenty":-21.83275,"median":-21.378316,"eighty":-21.121888,"marketCap":144726120},{"date":"2021-03-12","current":-21.057477,"twenty":-21.702996,"median":-21.336928,"eighty":-21.039295,"marketCap":144583110},{"date":"2021-03-19","current":-20.921405,"twenty":-21.589261,"median":-21.248455,"eighty":-20.956826,"marketCap":143153010},{"date":"2021-03-26","current":-20.670206,"twenty":-21.547958,"median":-21.13039,"eighty":-20.79868,"marketCap":140149800},{"date":"2021-04-01","current":-20.845813,"twenty":-21.531241,"median":-21.121823,"eighty":-20.817601,"marketCap":141007860},{"date":"2021-04-09","current":-21.225903,"twenty":-21.467898,"median":-21.109261,"eighty":-20.79095,"marketCap":145012140},{"date":"2021-04-16","current":-20.537749,"twenty":-21.367336,"median":-21.07922,"eighty":-20.761675,"marketCap":141436890},{"date":"2021-04-23","current":-20.315019,"twenty":-21.347758,"median":-20.984107,"eighty":-20.655391,"marketCap":140864850},{"date":"2021-04-30","current":-20.575716,"twenty":-21.338162,"median":-20.952872,"eighty":-20.552936,"marketCap":142294950},{"date":"2021-05-07","current":-20.262992,"twenty":-21.300508,"median":-20.893278,"eighty":-20.441966,"marketCap":141579900},{"date":"2021-05-14","current":-20.126121,"twenty":-21.252461,"median":-20.822297,"eighty":-20.370365,"marketCap":140435820},{"date":"2021-05-21","current":-20.063477,"twenty":-21.239434,"median":-20.785932,"eighty":-20.317104,"marketCap":140578830},{"date":"2021-05-28","current":-9.074203,"twenty":-21.215604,"median":-20.72844,"eighty":-20.270407,"marketCap":63580250},{"date":"2021-06-04","current":-9.099058,"twenty":-21.186359,"median":-20.671226,"eighty":-20.246426,"marketCap":63645797},{"date":"2021-06-11","current":-20.256213,"twenty":-21.131171,"median":-20.62297,"eighty":-20.108533,"marketCap":140864850},{"date":"2021-06-18","current":-20.772768,"twenty":-21.130859,"median":-20.59844,"eighty":-20.118,"marketCap":141579900},{"date":"2021-06-25","current":-20.724223,"twenty":-21.128116,"median":-20.62297,"eighty":-20.123197,"marketCap":142294950},{"date":"2021-07-02","current":-20.626893,"twenty":-21.122017,"median":-20.616149,"eighty":-20.125343,"marketCap":140435820},{"date":"2021-07-09","current":-20.380574,"twenty":-21.1215,"median":-20.614557,"eighty":-20.126121,"marketCap":139005720},{"date":"2021-07-16","current":-20.519425,"twenty":-21.109261,"median":-20.575716,"eighty":-20.156594,"marketCap":139291740},{"date":"2021-07-23","current":-20.512371,"twenty":-21.100962,"median":-20.537878,"eighty":-20.242284,"marketCap":138719700},{"date":"2021-07-30","current":-20.299111,"twenty":-21.057477,"median":-20.519425,"eighty":-20.242284,"marketCap":138433680},{"date":"2021-08-06","current":-20.554664,"twenty":-21.012022,"median":-20.514719,"eighty":-20.242284,"marketCap":139005720},{"date":"2021-08-13","current":-20.447221,"twenty":-20.984107,"median":-20.517067,"eighty":-20.256213,"marketCap":138719700},{"date":"2021-08-20","current":-20.697321,"twenty":-20.975132,"median":-20.51883,"eighty":-20.262992,"marketCap":139005720},{"date":"2021-08-27","current":-20.379723,"twenty":-20.972644,"median":-20.518236,"eighty":-20.265529,"marketCap":138147660},{"date":"2021-09-03","current":-20.932843,"twenty":-20.9331,"median":-20.51883,"eighty":-20.267469,"marketCap":143010000},{"date":"2021-09-10","current":-20.672351,"twenty":-20.952117,"median":-20.526525,"eighty":-20.273344,"marketCap":140578830},{"date":"2021-09-17","current":-20.788911,"twenty":-20.935877,"median":-20.538007,"eighty":-20.294251,"marketCap":140292810},{"date":"2021-09-24","current":-20.925132,"twenty":-20.932894,"median":-20.56006,"eighty":-20.301276,"marketCap":140864850},{"date":"2021-10-01","current":-21.007107,"twenty":-20.973142,"median":-20.575716,"eighty":-20.306471,"marketCap":140006790},{"date":"2021-10-08","current":-21.151111,"twenty":-21.00809,"median":-20.581853,"eighty":-20.310016,"marketCap":140721840},{"date":"2021-10-15","current":-20.992495,"twenty":-21.033503,"median":-20.614435,"eighty":-20.314138,"marketCap":140006790},{"date":"2021-10-22","current":-20.979254,"twenty":-21.015601,"median":-20.620294,"eighty":-20.319189,"marketCap":140292810},{"date":"2021-10-29","current":-21.103709,"twenty":-21.049534,"median":-20.628022,"eighty":-20.340912,"marketCap":140292810},{"date":"2021-11-05","current":-21.161406,"twenty":-21.059496,"median":-20.645111,"eighty":-20.350832,"marketCap":140578830},{"date":"2021-11-12","current":-21.337744,"twenty":-21.068902,"median":-20.670206,"eighty":-20.353037,"marketCap":140435820},{"date":"2021-11-19","current":-21.577137,"twenty":-21.091056,"median":-20.678231,"eighty":-20.353298,"marketCap":140435820},{"date":"2021-11-26","current":-21.52096,"twenty":-21.108578,"median":-20.693694,"eighty":-20.355018,"marketCap":140006790},{"date":"2021-12-03","current":-21.5525,"twenty":-21.125131,"median":-20.706276,"eighty":-20.35641,"marketCap":139863780},{"date":"2021-12-10","current":-21.569806,"twenty":-21.155229,"median":-20.729118,"eighty":-20.357488,"marketCap":140292810},{"date":"2021-12-17","current":-21.444455,"twenty":-21.18744,"median":-20.755321,"eighty":-20.360981,"marketCap":139005720},{"date":"2021-12-23","current":-21.411047,"twenty":-21.239434,"median":-20.778281,"eighty":-20.367381,"marketCap":139291740},{"date":"2021-12-31","current":-21.326314,"twenty":-21.328981,"median":-20.793694,"eighty":-20.376349,"marketCap":139434750},{"date":"2022-01-07","current":-21.496624,"twenty":-21.347524,"median":-20.831373,"eighty":-20.380063,"marketCap":140149800},{"date":"2022-01-14","current":-21.343042,"twenty":-21.350709,"median":-20.845796,"eighty":-20.384765,"marketCap":140149800},{"date":"2022-01-21","current":-21.439355,"twenty":-21.390606,"median":-20.871892,"eighty":-20.394177,"marketCap":139792275},{"date":"2022-01-28","current":-21.81807,"twenty":-21.411007,"median":-20.878577,"eighty":-20.407434,"marketCap":140006790},{"date":"2022-02-04","current":-21.195343,"twenty":-21.415476,"median":-20.901854,"eighty":-20.412214,"marketCap":139434750},{"date":"2022-02-11","current":-21.331112,"twenty":-21.429778,"median":-20.921405,"eighty":-20.419903,"marketCap":139863780},{"date":"2022-02-18","current":-21.489301,"twenty":-21.43906,"median":-20.931009,"eighty":-20.423447,"marketCap":140006790},{"date":"2022-02-25","current":-21.593859,"twenty":-21.452754,"median":-20.936467,"eighty":-20.427355,"marketCap":139863780},{"date":"2022-03-04","current":-22.31244,"twenty":-21.464918,"median":-20.972644,"eighty":-20.428933,"marketCap":140006790},{"date":"2022-03-11","current":-22.266973,"twenty":-21.496624,"median":-20.979146,"eighty":-20.432589,"marketCap":140149800},{"date":"2022-03-18","current":-22.060307,"twenty":-21.513575,"median":-20.987624,"eighty":-20.434714,"marketCap":140292810},{"date":"2022-03-25","current":-22.254443,"twenty":-21.52344,"median":-20.998804,"eighty":-20.447221,"marketCap":140578830},{"date":"2022-04-01","current":-22.154187,"twenty":-21.542769,"median":-21.012022,"eighty":-20.451813,"marketCap":140578830},{"date":"2022-04-08","current":-22.481854,"twenty":-21.567321,"median":-21.030475,"eighty":-20.452843,"marketCap":140578830},{"date":"2022-04-14","current":-22.67216,"twenty":-21.569768,"median":-21.052463,"eighty":-20.467141,"marketCap":140864850},{"date":"2022-04-22","current":-22.730966,"twenty":-21.579562,"median":-21.057477,"eighty":-20.474288,"marketCap":140864850},{"date":"2022-04-29","current":-23.274023,"twenty":-21.614609,"median":-21.067729,"eighty":-20.476303,"marketCap":141007860},{"date":"2022-05-06","current":-23.127906,"twenty":-21.66066,"median":-21.076365,"eighty":-20.478189,"marketCap":140864850},{"date":"2022-05-13","current":-23.491752,"twenty":-21.687663,"median":-21.09477,"eighty":-20.47859,"marketCap":140578830},{"date":"2022-05-20","current":-23.178757,"twenty":-21.820243,"median":-21.108122,"eighty":-20.48606,"marketCap":140578830},{"date":"2022-05-27","current":-22.893849,"twenty":-21.850993,"median":-21.120918,"eighty":-20.491024,"marketCap":141007860},{"date":"2022-06-03","current":-22.874754,"twenty":-21.920045,"median":-21.125878,"eighty":-20.495924,"marketCap":140950656},{"date":"2022-06-10","current":-23.37928,"twenty":-22.019208,"median":-21.131171,"eighty":-20.503856,"marketCap":141436890},{"date":"2022-06-17","current":-23.535903,"twenty":-22.073973,"median":-21.161634,"eighty":-20.508764,"marketCap":141579900},{"date":"2022-06-24","current":-23.228366,"twenty":-22.168168,"median":-21.177519,"eighty":-20.510788,"marketCap":140864850},{"date":"2022-07-01","current":-23.628446,"twenty":-22.205389,"median":-21.200156,"eighty":-20.514249,"marketCap":141293880},{"date":"2022-07-08","current":-24.122583,"twenty":-22.267227,"median":-21.212539,"eighty":-20.517301,"marketCap":141150870},{"date":"2022-07-15","current":-24.331277,"twenty":-22.320478,"median":-21.237179,"eighty":-20.518474,"marketCap":141150870},{"date":"2022-07-22","current":-24.090008,"twenty":-22.423227,"median":-21.257719,"eighty":-20.52015,"marketCap":141579900},{"date":"2022-07-29","current":-24.168576,"twenty":-22.534118,"median":-21.31615,"eighty":-20.524441,"marketCap":141722910},{"date":"2022-08-05","current":-4.879205,"twenty":-22.582014,"median":-21.326314,"eighty":-20.52015,"marketCap":141722910},{"date":"2022-08-12","current":-4.837995,"twenty":-22.549115,"median":-21.276097,"eighty":-20.510261,"marketCap":141865920},{"date":"2022-08-19","current":-4.945659,"twenty":-22.534118,"median":-21.248455,"eighty":-20.488701,"marketCap":142008930},{"date":"2022-08-26","current":-4.973006,"twenty":-22.502765,"median":-21.218542,"eighty":-20.475462,"marketCap":142151940},{"date":"2022-09-02","current":-4.964584,"twenty":-22.470606,"median":-21.200156,"eighty":-20.448139,"marketCap":142437960},{"date":"2022-09-09","current":-4.95567,"twenty":-22.425612,"median":-21.178962,"eighty":-20.428933,"marketCap":142296380},{"date":"2022-09-16","current":-4.974555,"twenty":-22.424465,"median":-21.161634,"eighty":-20.410452,"marketCap":142580970},{"date":"2022-09-23","current":-5.117324,"twenty":-22.418277,"median":-21.131171,"eighty":-20.379723,"marketCap":142294950},{"date":"2022-09-30","current":-5.084236,"twenty":-22.409269,"median":-21.125878,"eighty":-20.356574,"marketCap":142580970},{"date":"2022-10-07","current":-5.099691,"twenty":-22.388089,"median":-21.120336,"eighty":-20.35202,"marketCap":142580970},{"date":"2022-10-14","current":-5.125907,"twenty":-22.322487,"median":-21.105916,"eighty":-20.310612,"marketCap":142866990},{"date":"2022-10-21","current":4.123596,"twenty":-22.31244,"median":-21.088579,"eighty":-20.274813,"marketCap":143153010},{"date":"2022-10-28","current":4.07957,"twenty":-22.287254,"median":-21.074661,"eighty":-20.256213,"marketCap":143582040},{"date":"2022-11-04","current":4.09622,"twenty":-22.281341,"median":-21.06757,"eighty":-20.156594,"marketCap":143725050},{"date":"2022-11-11","current":3.835525,"twenty":-22.267291,"median":-21.05741,"eighty":-20.116823,"marketCap":140221305},{"date":"2022-11-18","current":3.965158,"twenty":-22.266973,"median":-21.047582,"eighty":-20.01593,"marketCap":145441170},{"date":"2022-11-25","current":22.070496,"twenty":-22.256949,"median":-21.02751,"eighty":-19.909786,"marketCap":812319096},{"date":"2022-12-02","current":18.678955,"twenty":-22.224077,"median":-21.009565,"eighty":-9.20741,"marketCap":693258130},{"date":"2022-12-09","current":20.55276,"twenty":-22.194292,"median":-20.992495,"eighty":-9.076373,"marketCap":766661932},{"date":"2022-12-16","current":23.284761,"twenty":-22.183606,"median":-20.985866,"eighty":-5.170387,"marketCap":873913042},{"date":"2022-12-23","current":24.514364,"twenty":-22.180369,"median":-20.979037,"eighty":-5.136784,"marketCap":921625514},{"date":"2022-12-30","current":23.500927,"twenty":-22.176953,"median":-20.972644,"eighty":-5.116761,"marketCap":889001602},{"date":"2023-01-06","current":25.713628,"twenty":-22.168168,"median":-20.939833,"eighty":-5.097544,"marketCap":965994034},{"date":"2023-01-13","current":21.766355,"twenty":-22.156426,"median":-20.931009,"eighty":-5.061828,"marketCap":833540951},{"date":"2023-01-20","current":21.475872,"twenty":-22.142244,"median":-20.923268,"eighty":-5.030111,"marketCap":823753778},{"date":"2023-01-27","current":34.556535,"twenty":-22.087638,"median":-20.91043,"eighty":-4.995999,"marketCap":1327793218},{"date":"2023-02-03","current":27.072439,"twenty":-22.055719,"median":-20.885889,"eighty":-4.981646,"marketCap":1039887195},{"date":"2023-02-10","current":27.186532,"twenty":-22.037344,"median":-20.873676,"eighty":-4.977626,"marketCap":1027653228},{"date":"2023-02-17","current":28.847843,"twenty":-22.035695,"median":-20.845796,"eighty":-4.96732,"marketCap":1088823063},{"date":"2023-02-24","current":29.876152,"twenty":-22.029478,"median":-20.834633,"eighty":-4.95567,"marketCap":1115737790},{"date":"2023-03-03","current":27.302811,"twenty":-22.012361,"median":-20.798477,"eighty":-4.893553,"marketCap":1024390836},{"date":"2023-03-10","current":28.150355,"twenty":-21.957814,"median":-20.782106,"eighty":-4.871727,"marketCap":1062723933},{"date":"2023-03-17","current":28.619298,"twenty":-21.954448,"median":-20.755321,"eighty":-4.837995,"marketCap":1079851487},{"date":"2023-03-24","current":29.32388,"twenty":-21.934194,"median":-20.729118,"eighty":3.771219,"marketCap":1116553388},{"date":"2023-03-31","current":-12.752993,"twenty":-21.910612,"median":-20.706276,"eighty":3.835525,"marketCap":1081482682},{"date":"2023-04-06","current":-12.88881,"twenty":-21.90985,"median":-20.697321,"eighty":3.835227,"marketCap":1098610236},{"date":"2023-04-14","current":-12.801571,"twenty":-21.899263,"median":-20.678231,"eighty":3.825059,"marketCap":1104319421},{"date":"2023-04-21","current":-14.947443,"twenty":-21.850993,"median":-20.670206,"eighty":3.781482,"marketCap":1279672948},{"date":"2023-04-28","current":-13.55748,"twenty":-21.838695,"median":-20.645111,"eighty":3.746421,"marketCap":1166304854},{"date":"2023-05-05","current":-13.247519,"twenty":-21.837737,"median":-20.628022,"eighty":-3.085842,"marketCap":1137758931},{"date":"2023-05-12","current":-13.196444,"twenty":-21.830658,"median":-20.620294,"eighty":-4.801486,"marketCap":1124709366},{"date":"2023-05-19","current":-11.577513,"twenty":-21.820243,"median":-20.614435,"eighty":-4.83115,"marketCap":973024741},{"date":"2023-05-26","current":-12.873913,"twenty":-21.775441,"median":-20.581853,"eighty":-4.843609,"marketCap":1077686226},{"date":"2023-06-02","current":-13.4553,"twenty":-21.758764,"median":-20.576071,"eighty":-4.84735,"marketCap":1127563965},{"date":"2023-06-09","current":-11.336689,"twenty":-21.717141,"median":-20.565455,"eighty":-4.85482,"marketCap":953400713},{"date":"2023-06-16","current":-11.670779,"twenty":-21.688764,"median":-20.543917,"eighty":-4.866541,"marketCap":995114272},{"date":"2023-06-23","current":-11.565622,"twenty":-21.678904,"median":-20.533873,"eighty":-4.872917,"marketCap":989390525},{"date":"2023-06-30","current":-11.66219,"twenty":-21.66693,"median":-20.521238,"eighty":-4.875603,"marketCap":991025881},{"date":"2023-07-07","current":-11.380237,"twenty":-21.664978,"median":-20.517651,"eighty":-4.879205,"marketCap":964860181},{"date":"2023-07-14","current":-11.034638,"twenty":-21.662538,"median":-20.509733,"eighty":-4.882597,"marketCap":964042503},{"date":"2023-07-21","current":-11.170865,"twenty":-21.660191,"median":-20.495236,"eighty":-4.893553,"marketCap":971810445},{"date":"2023-07-28","current":-11.009662,"twenty":-21.656236,"median":-20.47859,"eighty":-4.916273,"marketCap":944418228},{"date":"2023-08-04","current":-10.763767,"twenty":-21.630704,"median":-20.475882,"eighty":-4.940196,"marketCap":919887885},{"date":"2023-08-11","current":-3.964027,"twenty":-21.619037,"median":-20.452843,"eighty":-4.879205,"marketCap":906805035},{"date":"2023-08-18","current":-4.026987,"twenty":-21.613502,"median":-20.440967,"eighty":-4.848908,"marketCap":909683857},{"date":"2023-08-25","current":-4.022548,"twenty":-21.606196,"median":-20.428933,"eighty":-4.792358,"marketCap":904744397},{"date":"2023-09-01","current":-3.768342,"twenty":-21.593859,"median":-20.420865,"eighty":-4.019699,"marketCap":848763852},{"date":"2023-09-08","current":-3.73793,"twenty":-21.590181,"median":-20.408566,"eighty":-4.001992,"marketCap":830652499},{"date":"2023-09-15","current":-3.712765,"twenty":-21.579562,"median":-20.380574,"eighty":-3.942259,"marketCap":822420066},{"date":"2023-09-22","current":-3.650753,"twenty":-21.575135,"median":-20.368501,"eighty":-3.858715,"marketCap":808424930},{"date":"2023-09-29","current":-3.421608,"twenty":-21.572125,"median":-20.356574,"eighty":-3.838428,"marketCap":750797898},{"date":"2023-10-06","current":-3.012194,"twenty":-21.570144,"median":-20.353296,"eighty":-3.76226,"marketCap":658594648},{"date":"2023-10-13","current":-2.686479,"twenty":-21.569768,"median":-20.346082,"eighty":-3.707338,"marketCap":588618966},{"date":"2023-10-20","current":-2.811146,"twenty":-21.56948,"median":-20.312815,"eighty":-3.654052,"marketCap":617432482},{"date":"2023-10-27","current":-2.375367,"twenty":-21.568992,"median":-20.309123,"eighty":-3.646351,"marketCap":519466528},{"date":"2023-11-03","current":-3.917302,"twenty":-21.567321,"median":-20.299111,"eighty":-3.544741,"marketCap":863582232},{"date":"2023-11-10","current":-3.597007,"twenty":-21.566303,"median":-20.266499,"eighty":-3.604286,"marketCap":800192497},{"date":"2023-11-17","current":-3.627589,"twenty":-21.562197,"median":-20.256213,"eighty":-3.537462,"marketCap":818303850},{"date":"2023-11-24","current":-3.529793,"twenty":-21.562057,"median":-20.239654,"eighty":-3.489083,"marketCap":799369254},{"date":"2023-12-01","current":-3.547582,"twenty":-21.5525,"median":-20.141357,"eighty":-3.52171,"marketCap":803485470},{"date":"2023-12-08","current":-3.307014,"twenty":-21.542769,"median":-20.122709,"eighty":-3.489083,"marketCap":740918979},{"date":"2023-12-15","current":-3.69562,"twenty":-21.533656,"median":-20.083807,"eighty":-3.52171,"marketCap":843824392},{"date":"2023-12-22","current":-4.035423,"twenty":-21.527619,"median":-20.01593,"eighty":-3.522576,"marketCap":921209263},{"date":"2023-12-29","current":-4.090708,"twenty":-21.52655,"median":-19.978248,"eighty":-3.526906,"marketCap":940967103},{"date":"2024-01-05","current":-4.344468,"twenty":-21.525358,"median":-19.920067,"eighty":-3.533351,"marketCap":988715215},{"date":"2024-01-12","current":-6.195434,"twenty":-21.52344,"median":-19.753335,"eighty":-3.548025,"marketCap":1408569303},{"date":"2024-01-19","current":-6.4217,"twenty":-21.52344,"median":-15.556029,"eighty":-3.549796,"marketCap":1448908225},{"date":"2024-01-26","current":-8.782403,"twenty":-21.52096,"median":-14.109091,"eighty":-3.557352,"marketCap":1976607187},{"date":"2024-02-02","current":-7.600825,"twenty":-21.513689,"median":-13.749102,"eighty":-3.569428,"marketCap":1712346084},{"date":"2024-02-09","current":-7.207212,"twenty":-21.513575,"median":-13.613957,"eighty":-3.588398,"marketCap":1611087157},{"date":"2024-02-16","current":-7.247938,"twenty":-21.506276,"median":-13.555523,"eighty":-3.597007,"marketCap":1619319590},{"date":"2024-02-23","current":-8.32854,"twenty":-21.504386,"median":-13.501613,"eighty":-3.6123,"marketCap":1870809159},{"date":"2024-03-01","current":-11.523207,"twenty":-21.501535,"median":-13.4553,"eighty":-3.617449,"marketCap":2038881713},{"date":"2024-03-08","current":-10.554531,"twenty":-21.497487,"median":-13.312518,"eighty":-3.621659,"marketCap":1867487103},{"date":"2024-03-15","current":-11.064095,"twenty":-21.496624,"median":-13.247519,"eighty":-3.626597,"marketCap":1957647810},{"date":"2024-03-22","current":-11.326445,"twenty":-21.490766,"median":-13.177305,"eighty":-3.630464,"marketCap":2004067183},{"date":"2024-03-28","current":-11.452575,"twenty":-21.477499,"median":-13.148196,"eighty":-3.631217,"marketCap":2026384190},{"date":"2024-04-05","current":-10.801745,"twenty":-21.466803,"median":-12.946408,"eighty":-3.632099,"marketCap":1911228436},{"date":"2024-04-12","current":-10.055058,"twenty":-21.461539,"median":-12.894895,"eighty":-3.633023,"marketCap":1779111758},{"date":"2024-04-19","current":-9.807844,"twenty":-21.456824,"median":-12.873913,"eighty":-3.633343,"marketCap":1735370425},{"date":"2024-04-26","current":-10.816881,"twenty":-21.455182,"median":-12.8124,"eighty":-3.637723,"marketCap":1913906477},{"date":"2024-05-03","current":-11.469203,"twenty":-21.453725,"median":-12.730824,"eighty":-3.642957,"marketCap":2029326298},{"date":"2024-05-10","current":-8.594704,"twenty":-21.447775,"median":-12.51454,"eighty":-3.64496,"marketCap":1965488386},{"date":"2024-05-17","current":-7.883065,"twenty":-21.443062,"median":-12.154706,"eighty":-3.648552,"marketCap":1802746667},{"date":"2024-05-24","current":-7.51567,"twenty":-21.440467,"median":-11.944691,"eighty":-3.653227,"marketCap":1718728474},{"date":"2024-05-31","current":-7.287445,"twenty":-21.438765,"median":-11.913972,"eighty":-3.657432,"marketCap":1666536719},{"date":"2024-06-07","current":-7.712415,"twenty":-21.436028,"median":-11.820873,"eighty":-3.667469,"marketCap":1763721366},{"date":"2024-06-14","current":-7.649457,"twenty":-21.431796,"median":-11.712329,"eighty":-3.679697,"marketCap":1749323640},{"date":"2024-06-21","current":-6.779842,"twenty":-21.425982,"median":-11.674804,"eighty":-3.69138,"marketCap":1550455058},{"date":"2024-06-28","current":-7.688806,"twenty":-21.424034,"median":-11.670779,"eighty":-3.693076,"marketCap":1758322219},{"date":"2024-07-05","current":-7.869811,"twenty":-21.420068,"median":-11.629156,"eighty":-3.69699,"marketCap":1799715680},{"date":"2024-07-12","current":-8.259367,"twenty":-21.415476,"median":-11.571568,"eighty":-3.704241,"marketCap":1888801606},{"date":"2024-07-15","current":-7.818658,"twenty":-21.415058,"median":-11.565622,"eighty":-3.706013,"marketCap":1788017528},{"date":"2024-08-02","current":-6.78968,"twenty":-21.414641,"median":-11.56183,"eighty":-3.707784,"marketCap":1552704702},{"date":"2024-08-09","current":-6.633158,"twenty":-21.412151,"median":-11.523207,"eighty":-3.71219,"marketCap":1521659607},{"date":"2024-08-16","current":-6.431294,"twenty":-21.410928,"median":-11.485219,"eighty":-3.714995,"marketCap":1475351701},{"date":"2024-08-23","current":-6.486229,"twenty":-21.403699,"median":-11.452575,"eighty":-3.729351,"marketCap":1487953851},{"date":"2024-08-30","current":-6.3175,"twenty":-21.396025,"median":-11.40917,"eighty":-3.756177,"marketCap":1449247247},{"date":"2024-09-06","current":-6.35674,"twenty":-21.393924,"median":-11.355092,"eighty":-3.77086,"marketCap":1458248783},{"date":"2024-09-13","current":-6.278261,"twenty":-21.387534,"median":-11.326445,"eighty":-3.775122,"marketCap":1440245712},{"date":"2024-09-20","current":-6.301805,"twenty":-21.376871,"median":-11.275775,"eighty":-3.783142,"marketCap":1445646633},{"date":"2024-09-27","current":-6.211555,"twenty":-21.365168,"median":-11.250767,"eighty":-3.799975,"marketCap":1424943101},{"date":"2024-10-04","current":-6.894316,"twenty":-21.350709,"median":-11.235632,"eighty":-3.813963,"marketCap":1581569822},{"date":"2024-10-11","current":-6.913935,"twenty":-21.347524,"median":-11.180631,"eighty":-3.822859,"marketCap":1586070590},{"date":"2024-10-18","current":-7.467207,"twenty":-21.343075,"median":-11.167175,"eighty":-3.825993,"marketCap":1712992243},{"date":"2024-10-25","current":-7.400501,"twenty":-21.342938,"median":-11.154909,"eighty":-3.828323,"marketCap":1697689633},{"date":"2024-10-31","current":-7.063044,"twenty":-21.342346,"median":-11.153652,"eighty":-3.831162,"marketCap":1620276426},{"date":"2024-11-08","current":-10.245268,"twenty":-21.340032,"median":-11.119592,"eighty":-3.843127,"marketCap":2037947682},{"date":"2024-11-15","current":-11.597233,"twenty":-21.336418,"median":-11.153652,"eighty":-3.852751,"marketCap":2306875223},{"date":"2024-11-22","current":-9.344667,"twenty":-21.331041,"median":-11.139145,"eighty":-3.855094,"marketCap":1858803744},{"date":"2024-11-29","current":-9.219266,"twenty":-21.330759,"median":-11.119592,"eighty":-3.856223,"marketCap":1833859559},{"date":"2024-12-06","current":-8.392551,"twenty":-21.326314,"median":-11.114547,"eighty":-3.859338,"marketCap":1669412707},{"date":"2024-12-13","current":-11.652967,"twenty":-21.305987,"median":-11.115575,"eighty":-3.87719,"marketCap":2317961528},{"date":"2024-12-20","current":-11.824812,"twenty":-21.294475,"median":-11.119592,"eighty":-3.877993,"marketCap":2352144301},{"date":"2024-12-27","current":-12.182436,"twenty":-21.26507,"median":-11.153652,"eighty":-3.894887,"marketCap":2423281422},{"date":"2025-01-03","current":-13.971232,"twenty":-21.256167,"median":-11.154909,"eighty":-3.910026,"marketCap":2779101565},{"date":"2025-01-10","current":-13.750577,"twenty":-21.252461,"median":-11.164306,"eighty":-3.918163,"marketCap":2735209745},{"date":"2025-01-17","current":-12.604247,"twenty":-21.239434,"median":-11.175748,"eighty":-3.920305,"marketCap":2507186388},{"date":"2025-01-24","current":-12.485847,"twenty":-21.225631,"median":-11.191789,"eighty":-3.922976,"marketCap":2483634680},{"date":"2025-01-31","current":-11.716245,"twenty":-21.222143,"median":-11.235632,"eighty":-3.931982,"marketCap":2330548577},{"date":"2025-02-07","current":-11.355662,"twenty":-21.212096,"median":-11.250762,"eighty":-3.948487,"marketCap":2258822920},{"date":"2025-02-14","current":-10.440751,"twenty":-21.20829,"median":-11.235632,"eighty":-3.960565,"marketCap":2076832448},{"date":"2025-02-21","current":-10.225478,"twenty":-21.200156,"median":-11.183444,"eighty":-3.964027,"marketCap":2034011161},{"date":"2025-02-28","current":-9.504592,"twenty":-21.195343,"median":-11.175748,"eighty":-3.98226,"marketCap":2296290448},{"date":"2025-03-07","current":-10.681871,"twenty":-21.178962,"median":-11.164306,"eighty":-3.997428,"marketCap":2580718582},{"date":"2025-03-14","current":-10.718234,"twenty":-21.176077,"median":-11.154835,"eighty":-4.003133,"marketCap":2589504006},{"date":"2025-03-21","current":-10.940963,"twenty":-21.161863,"median":-11.124637,"eighty":-4.016201,"marketCap":2643314734},{"date":"2025-03-28","current":-10.186414,"twenty":-21.161406,"median":-11.118097,"eighty":-4.018359,"marketCap":2461017166},{"date":"2025-04-04","current":-8.181858,"twenty":-21.151111,"median":-11.108408,"eighty":-4.019699,"marketCap":1976720616},{"date":"2025-04-11","current":-6.772761,"twenty":-21.131171,"median":-11.085541,"eighty":-4.022548,"marketCap":1636285398},{"date":"2025-04-17","current":-7.286399,"twenty":-21.131171,"median":-11.049366,"eighty":-4.026099,"marketCap":1760379526},{"date":"2025-04-25","current":-7.940948,"twenty":-21.129921,"median":-11.009301,"eighty":-4.031104,"marketCap":1918517175},{"date":"2025-04-28","current":-7.963675,"twenty":-21.129609,"median":-11.007855,"eighty":-4.032133,"marketCap":1924008066}],"updateTime":1745992344397}}}